Mesoderma - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 906,914 | 1,067,576 | 1,128,557 | 1,790,009 | 2,232,329 | 2,315,757 | 2,282,322 | 2,365,551 |
| Profit before tax | 23,681 | 29,036 | 13,227 | 92,411 | 678,599 | 193,435 | 215,012 | 93,230 |
| Net profit | 21,211 | 24,678 | 11,228 | 78,540 | 649,409 | 164,215 | 181,835 | 73,933 |
| Equity | 104,987 | 179,708 | 190,936 | 316,565 | 481,615 | 645,831 | 827,849 | 890,252 |
| Liabilities | 259,407 | 247,966 | 379,317 | 543,921 | 467,477 | 510,574 | 500,086 | 676,016 |
| Non-current assets | 101,580 | 99,158 | 87,017 | 88,596 | 108,316 | 160,470 | 186,658 | 248,761 |
| Current assets | 262,814 | 328,516 | 483,236 | 771,890 | 840,776 | 995,935 | 1,141,277 | 1,315,115 |
| Total assets | 364,394 | 427,674 | 570,253 | 860,486 | 949,092 | 1,156,405 | 1,327,935 | 1,563,876 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 344,176 | 332,606 | 368,525 |
| Social insurance contributions | - | - | - | - | - | 44,609 | 49,961 | 71,483 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +10.1% | +17.7% | +5.7% | +58.6% | +24.7% | +3.7% | -1.4% | +3.6% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 5.8% | 5.8% | 2.0% | 9.1% | 68.4% | 14.2% | 13.7% | 4.7% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 20.2% | 13.7% | 5.9% | 24.8% | 134.8% | 25.4% | 22.0% | 8.3% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 2.3% | 2.3% | 1.0% | 4.4% | 29.1% | 7.1% | 8.0% | 3.1% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 2.6% | 2.7% | 1.2% | 5.2% | 30.4% | 8.4% | 9.4% | 3.9% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 2.5 | 1.4 | 2.0 | 1.7 | 1.0 | 0.8 | 0.6 | 0.8 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 71,131 | 72,378 | 102,596 | 126,353 | 127,562 | 170,486 | 166,999 | 162,210 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Mesoderma - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2026-01-21 | 2026-02-11 | 0.01 |
| 2026-01-16 | 2026-01-19 | 238.07 |
| 2025-10-16 | 2025-10-19 | 10.94 |
| 2025-03-18 | 2025-03-20 | 67.66 |
| 2025-01-16 | 2025-01-19 | 114.17 |
| 2024-03-19 | 2024-04-11 | 0.56 |
Mesoderma - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2026-08-13 | 2026-08-13 | 4610.6 |
| 2026-02-21 | 2026-02-21 | 1751.43 |
| 2025-07-10 | 2025-07-20 | 1813.87 |
| 2025-06-02 | 2025-06-10 | 14.6 |
| 2025-05-31 | 2025-06-01 | 2.8 |
| 2025-05-29 | 2025-05-30 | 22.0 |
| 2025-05-20 | 2025-05-20 | 487.65 |
| 2025-05-19 | 2025-05-19 | 487.26 |
| 2025-05-17 | 2025-05-18 | 487.13 |
| 2025-05-13 | 2025-05-16 | 487.0 |
| 2025-03-08 | 2025-03-12 | 1288.06 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Mesoderma, UAB (code 302633438) is a Private Limited Liability Company engaged in wholesale of perfume and cosmetics. In 2025, the company generated revenue of €2.37M, up 3.6% year on year and 2.1% over two years. Net profit decreased to €73.9K from €181.8K in 2024 and €164.2K in 2023, while profit before tax also fell to €93.2K. As a result, the profit margin narrowed to 3.1% in 2025 from 8.0% in 2024 and 7.1% in 2023. The revenue trend over the last three years remained broadly stable, but profitability weakened materially in the latest year. At the balance sheet level, total assets increased to €1.56M, equity rose to €890.3K, and liabilities grew to €676.0K in 2025. The equity ratio was 56.9% and debt-to-equity stood at 0.76. Asset turnover reached 1.51x, ROE was 8.3%, and ROA was 4.7%. Revenue per employee was €169.0K, with profit per employee at €5.3K, indicating solid sales productivity but lower earnings efficiency in 2025.